Karen has more than 20 years experience recruiting CEOs, senior management teams, and board members for a range of established and emerging life science companies, both investor-backed and public.
She is dedicated to building leadership teams with client companies that are developing breakthrough therapies and leveraging innovation in science, digital technologies, and related fields across the broad spectrum of healthcare. Notable client successes include: Immunomedics, sold to Gilead; Cascadian Therapeutics, sold to Seattle Genetics; GeneWEAVE, sold to Roche.
Karen excels in identifying and recruiting talent that can lead and guide an organization to the next level. Many of her client relationships are long term collaborations where she continually engages as a thought partner to support mapping the leadership evolution of a maturing organization.